Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Change in Receivables (2018 - 2026)

Viemed Healthcare filings provide 8 years of Change in Receivables readings, the most recent being -$1.8 million for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 14.58% to -$1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.2 million, a 119.07% decrease, with the full-year FY2025 number at -$1.2 million, down 119.07% from a year prior.
  • Change in Receivables hit -$1.8 million in Q4 2025 for Viemed Healthcare, down from -$968000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $6.0 million in Q1 2024 to a low of -$2.8 million in Q2 2022.
  • Median Change in Receivables over the past 5 years was $480000.0 (2021), compared with a mean of $793700.0.
  • Biggest five-year swings in Change in Receivables: soared 598.64% in 2024 and later crashed 7966.67% in 2025.
  • Viemed Healthcare's Change in Receivables stood at $1.8 million in 2021, then plummeted by 77.6% to $397000.0 in 2022, then soared by 32.24% to $525000.0 in 2023, then crashed by 507.62% to -$2.1 million in 2024, then rose by 14.58% to -$1.8 million in 2025.
  • The last three reported values for Change in Receivables were -$1.8 million (Q4 2025), -$968000.0 (Q3 2025), and -$240000.0 (Q2 2025) per Business Quant data.